The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective
COMPASS 试验中利伐沙班联合阿司匹林治疗与单独使用阿司匹林的成本效益比较：美国视角
期刊:American Journal of Cardiovascular Drugs
影响因子:2.8
doi:10.1007/s40256-023-00620-6
Andre Lamy, John Eikelboom, Wesley Tong, Fei Yuan, Shrikant I Bangdiwala, Jackie Bosch, Stuart Connolly, Eva Lonn, Gilles R Dagenais, Kelley R H Branch, Wei-Jhih Wang, Deepak L Bhatt, Jeffrey Probstfield, Georg Ertl, Stefan Störk, P Gabriel Steg, Victor Aboyans, Isabelle Durand-Zaleski, Lars Ryden,
